Medicines Development & Delivery
BiologIC Technologies is developing the first world's biocomputer leveraging foundational IP and the latest 3D printing technologies.
Visit company siteRichard Vellacott
CEO
Using an innovative platform technology called PODS, Cell Guidance Systems can stabilize and sustainably release proteins for a variety of applications.
Visit company siteMichael Jones
Founder & CEO
A specialist biotech company focused on developing 3D printing technology for fabricating pharmaceuticals and medical devices.
Visit company siteDr Alvaro Goyanes
CEO
LightOx has developed a new light activated chemotherapy drug for the treatment and prevention of early-stage oral cancers and is current taking this drug into clinical trials.
Visit company siteDr Sam Whitehouse
CEO
Medherant develops patches for transdermal drug delivery using a novel, proprietary, solvent-free adhesive technology.
Visit company siteNigel Davis
Chief Business Officer
Offering a flexible manufacturing platform that closes, automates and standardizes cell and gene therapy manufacturing.
Visit company siteJason Foster
CEO
A regenerative medicine company, pioneering synthetic nanoclays as a delivery platform for safe and precise tissue regeneration.
Visit company siteAgnieszka Janeczek
CEO
Supporting RNA delivery through its proprietary Bio-Courier® technology with the hybridization of organic materials with inorganic bioabsorbable silicon.
Visit company siteSuzanne Saffie-Siebert
Founder & CEO
A biotechnology company dedicated to delivering effective and safe nucleic acid therapies to save lives and improve health.
Visit company siteShadi Farhangrazi
CEO
Category Winners
See our 2023 Category Winners
Meet our 6 Category Winners selected for being market leading
UK Innovators in life sciences.